VASCULAR INFLAMMATION

Clinical trials for VASCULAR INFLAMMATION explained in plain language.

Never miss a new study

Get alerted when new VASCULAR INFLAMMATION trials appear

Sign up with your email to follow new studies for VASCULAR INFLAMMATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 2 Not yet recruiting 1 Not yet finished but already full! 1

New trial targets hidden genetic driver of heart disease inflammation

Disease control Not yet recruiting

This study is testing whether a drug called canakinumab can reduce dangerous inflammation in the arteries of people who have had a heart attack or stent. It specifically includes people with and without a common age-related genetic change called TET2 CHIP. Researchers will use he…

Matched conditions: VASCULAR INFLAMMATION

Phase: PHASE2 • Sponsor: Massachusetts General Hospital • Aim: Disease control

Last updated Mar 20, 2026 14:48 UTC

VASCULAR INFLAMMATION

Get alerted when new VASCULAR INFLAMMATION trials appear

New trial targets hidden genetic driver of heart disease inflammation